REQUEST A DEMO
Total
USD $0.00
Search more companies

Logimedica S.A.S. (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Logimedica S.A.S. Profile Updated: April 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Logimedica S.A.S. is an enterprise located in Colombia, with the main office in Medellin. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was established on September 23, 2016. The total number of employees is currently 5 (2023). In its most recent financial highlights, the company reported a net sales revenue increase of 92.86% in 2023. Over the same period, its total assets grew by 98.79%. In 2023, Logimedica S.A.S.’s net profit margin increased by 72.7%.

Headquarters
Calle 10 Sur 51 A 55 Local 505
Medellin; Antioquia;

Contact Details: Purchase the Logimedica S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Logimedica S.A.S. report to view the information.
Outstanding Shares:
Purchase the Logimedica S.A.S. report to view the information.
Incorporation Date:
September 23, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Logimedica S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
92.86%
Total operating revenue
92.86%
Operating profit (EBIT)
1345.54%
Net Profit (Loss) for the Period
1386.53%
Total assets
98.79%
Total equity
110.39%
Operating Profit Margin (ROS)
73.23%
Net Profit Margin
72.7%
Return on Equity (ROE)
45.06%
Quick Ratio
24.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?